Updated 10 October 2026.
QUARTIZ exosome treatment at Mahan
Mahan currently uses QUARTIZ exosome. Depending on the skin assessment, the doctor considers injection or Dermapen microneedling. These are different methods; the proposed route and product information are discussed before you decide.
Ask the clinician about the product’s ingredients, source, registration, approved uses and the evidence for your concern. Those product-specific details must be explained in the clinical consultation.
What does the term exosome mean?
Exosomes are small vesicles released by cells. “Exosome” is a broad term, so ask what the exact product contains and what evidence supports it. Product information and evidence should be considered separately from the treatment’s marketing name.
How is the method selected?
- The doctor assesses the skin concern and relevant treatment and medical history.
- The clinic explains the QUARTIZ product being considered and the proposed use.
- Injection and Dermapen microneedling are discussed as different procedures, not interchangeable protocols.
- The doctor considers suitability, limitations, alternatives and whether another route or no treatment is more appropriate.
What should be discussed before treatment?
- The exact product information and proposed treatment area.
- The evidence and regulatory context relevant to that product and method.
- Your health conditions, medicines, allergies, previous procedures and reactions.
- Possible risks, discomfort, aftercare, review and what to do if symptoms concern you.
- Appointment duration, price and any proposed number of visits.
Evidence and safety limitations
A biological origin does not, by itself, prove that a product is safe or unlikely to cause an adverse reaction. QUARTIZ may not suit every age or skin concern, and it isn’t claimed to stimulate collagen faster, improve scars or work better than PRP or laser treatment.
The FDA’s public safety notification describes serious adverse-event reports involving unapproved products marketed as containing exosomes and states that there are no FDA-approved exosome products. This is US regulatory information; ask the clinic about the product’s status in the UAE.
Results, recovery and aftercare
No fixed response, onset time, duration of effect or recovery period is promised. Ask the doctor what is known about the proposed product and method, what remains uncertain and what aftercare applies to your plan.
Follow the individual instructions provided at the appointment. If you experience concerning symptoms after a procedure, seek medical advice rather than relying on this general page or a social-media protocol.
Cost and number of sessions
Contact Mahan for current pricing. The doctor discusses whether a course of treatment suits you and how many sessions, if any, you might need.
Frequently asked questions
Which exosome product does Mahan currently use?
QUARTIZ. The clinic confirms the exact product information in the consultation.
Is the method injection or microneedling?
The doctor considers injection or Dermapen microneedling depending on the skin assessment. Ask why the proposed method fits your plan.
Does the treatment name mean it is approved for my concern?
No. Product identity, applicable registration, intended use, evidence and suitability are separate questions.
Can it be combined with another treatment?
Any combination requires an individual assessment of the methods, skin condition, recent procedures, risks and alternatives.
How can I arrange a consultation?
Read the skin-treatment service guide, contact Mahan or message the clinic on WhatsApp.